News

Secondary Cancers Resurface in Lenalidomide Maintenance Trial Data

Publish date: May 6, 2011

 

This coverage is provided courtesy of "The Pink Sheet." "The Pink Sheet" and Internal Medicine News Digital Network are both owned by Elsevier.

Pages

Recommended Reading

Wearable Electric Fields Device Approved for Brain Tumors
MDedge Internal Medicine
Early Results Promising for Robotic Pancreatic Resection
MDedge Internal Medicine
Lymphatic Invasion Predicts Recurrence in Merkel Cell Cancer
MDedge Internal Medicine
Nontoxic Goiter Tied to Higher Risk of Breast Cancer
MDedge Internal Medicine
Study: Diabetes Linked With Cancer and Cancer Mortality Risk
MDedge Internal Medicine
Cancer Risk 50% Greater in Treated RA Patients Than in General Population
MDedge Internal Medicine
FDA Approves Abiraterone for Castration-Resistant Prostate Cancer
MDedge Internal Medicine
Minimally Invasive Esophagectomy Leads to Low Mortality
MDedge Internal Medicine
Change in Mammography Guidelines May Adversely Affect Young Minority Women
MDedge Internal Medicine
Radical Prostatectomy Continues to Cut Mortality After 15 Years
MDedge Internal Medicine